Purpose: To assess and compare dacryocystography and lacrimal scintigraphy in the management of patients with epiphora and patent but nonfunctioning lacrimal systems.
Methods: Data were collected retrospectively over a 3-year period from all patients having both dacryocystography and lacrimal scintigraphy for epiphora where clinical examination indicated delayed tear clearance but the lacrimal system was patent. Both investigations were evaluated for presence, site, and severity of delayed clearance. Dacryocystograms were also evaluated for reflux and anatomical abnormalities. The findings were assessed in a masked fashion and compared with the clinical examination.
Results: More than 200 lacrimal systems in 107 patients were examined. An abnormality was present in one or both investigations in 92% of systems. There was greater agreement between clinical evaluation and scintigraphy than for dacryocystography. Abnormalities were detected with scintigraphy and dacryocystography in 78% and 56% of systems (25% delay, 11% anatomical abnormalities, and 20% both), respectively. Overall agreement was 52%. Disagreement occurred mainly with a normal dacryocystogram and abnormal scintigram. There was agreement for site of blockage in 59%; however, scintigraphy detected a block at a more proximal level in 38%.
Conclusions: In the investigation of epiphora in patients with apparent outflow obstruction but patent lacrimal systems, both dacryocystography and scintigraphy are often abnormal. The authors' study shows that scintigraphy is the more sensitive test, correlating more closely with the clinical examination and often detecting more proximal and severe obstruction, and appears to be the investigation of choice in these patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/IOP.0b013e3181a2ef32 | DOI Listing |
Curr Eye Res
January 2025
Govindram Seksaria Institute of Dacryology, L.V. Prasad Eye Institute, Hyderabad, India.
Purpose: To evaluate the role of computed tomography-dacryocystography (CT-DCG) in the management of traumatic secondary acquired lacrimal duct obstruction (SALDO) and study its correlation with the intra-operative findings.
Methods: Retrospective interventional case series. Eighty-five lacrimal drainage systems (LDS) of 79 patients diagnosed with traumatic SALDO, who underwent pre-operative CT-DCG, between January 2019 and June 2023, were analyzed.
J Craniofac Surg
January 2025
National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Aim: This research was designed to make a comparison of the treatment outcomes of endoscopic dacryocystorhinostomy (En-DCR) in nasolacrimal duct obstruction (NLDO) with and without chronic dacryocystitis.
Methods: NLDO (obstruction group) and chronic dacryocystitis (dacryocystitis group) patients treated with En-DCR in the Eye Hospital of Wenzhou Medical University from March 2021 to February 2022 were retrospectively analyzed. According to CT dacryocystography, patients in each group were assigned into the high obstruction group (obstruction located in the lacrimal sac) and the low obstruction group (obstruction located at or below the junction of the nasolacrimal duct and dacryocystis).
J Craniofac Surg
December 2024
Konkuk University School of Medicine, Chungju City, Republic of Korea.
Radiography (Lond)
January 2025
Department of Ophthalmology, Sussex Eye Hospital, Eastern Road, Kemptown, Brighton, BN2 5BF, United Kingdom.
J Craniofac Surg
November 2024
School of Medicine, Konkuk University.
Dacryocystography (DCG) has been used to illustrate the morphological and functional aspects of the lacrimal drainage system in the evaluation of patients with maxillofacial trauma and epiphora. This study developed deep-learning models for the automatic classification of the status of the lacrimal passage based on DCG. The authors collected 719 DCG images from 430 patients with nasolacrimal duct obstruction.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!